Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Generics Threaten Drugmaker Cephalon's Success
- Biotechnology watchers are measuring success at Cephalon on how quickly the drugmaker can convert patients on its soon-to-go generic blockbuster Provigil to regular users of its narcoleptic successor Nuvigil. As Jim Edwards at BNET Pharma astutely pointed out exactly one year ago, however, competition also threatens to derail...
- Blog posts 2009-09-21
- << Previous
- page 1 of 1
- Next >>